MedPath

RENEWING HEALTH - RegioNs of Europe WorkINg Together for HEALTH

Not Applicable
Completed
Conditions
Coronary Artery Disease
Heart Failure
Atrial Fibrillation
Other Arrhythmias
Type 2 Diabetes
Interventions
Behavioral: Health coaching
Registration Number
NCT01310491
Lead Sponsor
South Karelia, Social and Health Care District
Brief Summary

The purpose of this trial is to determine if by structured telephone based health coaching programme supported by remote monitoring system among type 2 diabetes, coronary artery disease and heart failure patients the investigators are able to improve their quality of life as measured by the SF-36 questionnaire and reduce a value of HbA1c under 6,5 % among those type 2 diabetes patients who had elevated value of HbA1c when recruited.

Detailed Description

RENEWING HEALTH is a project covering 9 different European States. It aims at evaluation of innovative telemedicine services using a patient-centred approach and a common rigorous assessment methodology. In 9 European regions in the implementation of health-related information and communication technologies service solutions are already operational at local level for the remote monitoring and the treatment of chronic patients suffering from diabetes,chronic obstructive pulmonary disease or cardiovascular diseases. The services are designed to give patients a central role in the management of their own diseases, fine-tuning the choice and dosage of medications, promoting compliance to treatment, and helping health care professionals to detect early signs of worsening in the monitored pathologies. Every area will designed its own real-life trial with certain common elements.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
595
Inclusion Criteria
  • Age > 18 years

  • Capability of filling in questionnaires in Finnish language.

  • Be able to use Remote Patient Monitoring System

  • Be able to use the devices provided

  • Has adequate cognitive capacities to participate

  • In their medical records, one or both of the following diagnoses:

    a) Type 2 Diabetes, for enrolment

  • diagnosed over 3 months prior to the enrolment and

  • HbA1c > 6,5 % b) Heart Disease, for enrolment

  • Ischemic heart disease or

  • Heart Failure or

  • Atrial fibrillation or

  • Other arrhythmia

  • Be able to walk

Exclusion Criteria
  • Not willing to participate (e.g., not willing to sign the consent)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual CareHealth coaching-
Primary Outcome Measures
NameTimeMethod
Health related quality of life12 months

Health related quality of life is assessed by the SF-36 questionnaire.

HbA1c change over time (participants with T2DM only)12 months
Secondary Outcome Measures
NameTimeMethod
Weight reduction12 months
Activity increase12 months
Alcohol use reduction12 months
Medication compliance12 months
Blood pressure reduction12 months
Smoke cessation12 months
Cost for the organization12 months
Satisfaction and usability of the technology and equipments.12 months

Trial Locations

Locations (1)

Etelä-Karjalan sosiaali- ja terveydenhuollon kuntayhtymä

🇫🇮

Lappeenranta, Finland

© Copyright 2025. All Rights Reserved by MedPath